S. Wong

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer

A. Khorana, N. Gabrail, R. Ramanathan, 2019, Oncology.

Abstract PD1-05: Latest findings from the breast cancer cohort in SUMMIT - a phase 2 ‘basket’ trial of neratinib + trastuzumab + fulvestrant forHER2-mutant, hormone receptor-positive, metastatic breast cancer

S. Loi, M. Burkard, H. Wildiers, 2021 .

CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab

B. Ganeshan, A. Groves, J. Bridgewater, 2015, Cancer Imaging.